Ovid Therapeutics Inc. - Common Stock — 현금 흐름 (NASDAQ:OVID) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -51.58 M118.61 M-55.23 M-45.78 M-55.96 M-38.33 M -41.95 M 투자 활동으로 인한 현금 34.65 M-1.82 M-87.88 M-2.58 M54.59 M-49.85 M -49.01 M 재무활동으로 인한 현금 47.07 M904.08 K180.66 K30.54 M622 K75.21 M 164.18 M 잉여 현금 흐름 -51.58 M118.61 M-55.23 M-45.78 M-55.96 M-38.33 M -41.95 M

뉴스

Ovid Therapeutics Inc. (OVID) Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders Transcript

3 Best Stocks to Buy Today, 4/7/2026, According to Top Analysts - TipRanks.com

Ovid Therapeutics: Seizing The Moment With Phase 2 Ready Assets And PIPE Funding

Ovid Therapeutics Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:OVID) 2026-03-19

Ovid Therapeutics (OVID) Q4 Earnings and Revenues Surpass Estimates

Niagen Bioscience (NAGE) Tops Q4 Earnings and Revenue Estimates

PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates

Ovid Therapeutics: Bullish Post-PIPE With Two Differentiated CNS Moonshots

Ovid’s KCC2 activator shows promising safety in early trial

오비드 테라퓨틱스, 주식 수 증가 및 관련 제안 승인

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals

오비드 테라퓨틱스, 뇌전증 치료제에 ’매수’ 등급